Literature DB >> 11395662

[Neurofibromatosis 1: recommendations for management].

S Pinson1, A Créange, S Barbarot, J F Stalder, Y Chaix, D Rodriguez, M Sanson, A Bernheim, M D'incan, F Doz, C Stoll, P Combemale, C Kalifa, J Zeller, D Teillac-Hamel, S Lyonnet, M Zerah, J P Lacour, B Guillot, P Wolkenstein.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11395662

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN： 0151-9638            Impact factor:   0.777


× No keyword cloud information.
  5 in total

1.  At-risk phenotype of neurofibromatose-1 patients: a multicentre case-control study.

Authors:  Emilie Sbidian; Sylvie Bastuji-Garin; Laurence Valeyrie-Allanore; Salah Ferkal; Jean P Lefaucheur; Alain Drouet; Pierre Brugière; Cédric Vialette; Patrick Combemale; Sébastien Barbarot; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2011-07-13       Impact factor: 4.123

2.  Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966.

Authors:  Christina Bergqvist; Amandine Servy; Laurence Valeyrie-Allanore; Salah Ferkal; Patrick Combemale; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2020-02-03       Impact factor: 4.123

3.  Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional study.

Authors:  Emilie Sbidian; Smaïl Hadj-Rabia; Vincent M Riccardi; Laurence L Valeyrie-Allanore; Sébastien Barbarot; Olivier Chosidow; Salah Ferkal; Diana Rodriguez; Pierre Wolkenstein; Sylvie Bastuji-Garin
Journal:  Orphanet J Rare Dis       Date:  2012-09-03       Impact factor: 4.123

4.  Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.

Authors:  Mehdi Brahmi; Philippe Thiesse; Dominique Ranchere; Thomas Mognetti; Stephane Pinson; Caroline Renard; Anne-Valérie Decouvelaere; Jean-Yves Blay; Patrick Combemale
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

5.  Utility of 18F-FDG PET with a semi-quantitative index in the detection of sarcomatous transformation in patients with neurofibromatosis type 1.

Authors:  Patrick Combemale; Laurence Valeyrie-Allanore; Francesco Giammarile; Stephane Pinson; Bernard Guillot; Denis Mariano Goulart; Pierre Wolkenstein; Jean Yves Blay; Thomas Mognetti
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.